Peptide purity is the percentage of chromatographic signal attributable to the main peak in a reversed-phase HPLC run, detected by UV absorbance. It counts peptide-related impurities only. Water, salts and counterions are invisible to the method, so purity and net peptide content are different numbers, established by different measurements.
- Peptide purity is an area-percent figure from RP-HPLC: the main peak's share of UV signal, measured under one set of conditions on one date.
- Water, trifluoroacetate counterions and salts are invisible to the purity method; net peptide content is a separate measurement and commonly 70 to 90% of gross mass.
- Identity requires mass spectrometry against the theoretical mass for the sequence; a purity figure alone cannot show that the main peak is the labeled peptide.
- Deletion sequences differing by a single residue are the classic co-eluting impurity and the main reason a purity figure can read high.
- A certificate of analysis is verifiable by matching lot numbers and confirming the report number with the named issuing laboratory.
The number is a chromatography result
A vial labeled 98% pure is reporting the outcome of one specific experiment. The lot was run through a reversed-phase HPLC column, a detector logged everything that came off it, and 98% of the integrated signal sat under the main peak. That is the whole claim. It is a statement about the proportions of peptide-related species in the sample, made under one set of chromatographic conditions, on one day.
Two things follow from the definition. The figure is relative: it compares the main peak against the other peaks in the same run, so anything the method cannot see is simply absent from the arithmetic. And it says nothing about quantity. A lot can be 99% pure while the vial holds substantially less peptide than the label mass suggests, because the purity method never weighed anything. Purity answers one question: of the peptide-related material present, how much is the target? It does not answer how much material is present, and it does not answer whether the target is what the label says it is. Those are separate questions with their own methods, and a competent certificate reports them separately.
None of this is a research-chemical quirk. Compendial and regulatory practice treats identity, purity and assay as distinct test attributes precisely because one measurement cannot carry all three claims at once.
How RP-HPLC produces the figure
The workhorse method is reversed-phase chromatography on a C18-modified silica column, running a gradient from water toward acetonitrile with roughly 0.1% trifluoroacetic acid as an ion-pairing agent. Hydrophobic species hold to the column longer. Each peptide-related component elutes at its own retention time, and a UV detector set near 214 nm, where the backbone amide bond absorbs, records the signal. Software integrates the area under every peak; the main peak's share of the total area is the purity figure.
Every step of that chain has a failure mode. Co-elution is the important one: an impurity with nearly the same retention behaviour as the target hides under the main peak and inflates the number. Deletion sequences missing one residue out of forty are the classic case, since dropping a single glycine changes hydrophobicity very little. Gradient shape matters as well. A steep gradient compresses the run and makes co-elution more likely; a shallow gradient over a longer run resolves more, and usually reports a lower and more honest figure. Detection wavelength is the third variable. At 214 nm the method sees peptide bonds, which means contaminants without a chromophore at that wavelength contribute nothing to the denominator and vanish from the result.
A purity figure travels with its method. A certificate stating the column, gradient and detection wavelength is reporting an experiment another laboratory could rerun. A bare percentage with none of that attached is an assertion.
What the figure does not establish
The purity percentage is silent on most of what a laboratory actually wants to know about a vial. The table maps the common questions to the methods that answer them.
| Question | Does RP-HPLC purity answer it? | What does |
|---|---|---|
| Is the main peak the right molecule? | No | Mass spectrometry: observed mass against the theoretical mass for the sequence |
| How much peptide is in the vial? | No | Net peptide content by amino acid analysis or nitrogen determination |
| Is the material sterile? | No | Sterility testing, rarely performed on research-grade lots |
| Is endotoxin present? | No | LAL assay, reported separately where offered |
| Are residual solvents within limits? | No | Gas chromatography, read against ICH residual-solvent classes |
| Has any residue racemized? | Usually not | Chiral methods; standard RP-HPLC rarely resolves epimers |
Net peptide content deserves the longest look, because it changes arithmetic people actually do. A lyophilized peptide is supplied as a salt, most often a trifluoroacetate, and the powder carries bound water alongside the counterion. It is routine for peptide to make up 70 to 90% of the gross mass, with the remainder being TFA and moisture the purity method never sees. A solution prepared from label mass alone overstates its own concentration by exactly that gap. Where the certificate reports net content, the vial concentration calculator arithmetic should start from the corrected figure rather than the label.
Identity is the other half. A 98% pure lot of the wrong peptide is a well-manufactured mistake. The mass spectrum, with an observed mass sitting within instrument tolerance of the theoretical value, is what ties the dominant peak to the sequence on the label. Purity and identity together support the claim a listing makes. Either one alone does not.
Reading the report
A certificate of analysis worth the name carries a specific set of fields, each checkable in seconds. The lot number must match the vial in hand; a certificate for a different lot is a certificate for different material. The analysis date should postdate synthesis and sit reasonably close to the ship date. The issuing laboratory should be named, whether that is the supplier's own facility or an independent one. And the analytical results should arrive with their evidence: a chromatogram behind the purity claim, a spectrum behind the identity claim, each with method conditions attached.
The chromatogram tells you more than the number extracted from it. A clean lot shows one dominant peak with small, resolved impurity peaks around it. Look for a shoulder, a bump on the flank of the main peak: a shoulder is co-elution caught in the act, something under the peak that the integration may be crediting to the target. A narrow, symmetric main peak over a flat baseline speaks well of both the material and the method.
Numbers reported past the method's plausibility are their own warning. A synthetic peptide of forty residues emerging at 99.99% describes a chromatogram that stepwise synthesis chemistry does not usually produce; even a flat 99% is a strong claim above about thirty residues. The plausible range for a well-made long peptide runs from the low nineties into the high nineties, and honest certificates show exactly that spread from lot to lot rather than the same immaculate figure every time.
Where the impurities come from
Solid-phase synthesis builds a peptide one residue at a time, and every coupling step has a yield below one hundred percent. The impurity profile of a finished lot is the fingerprint of that process, plus whatever chemistry has happened since.
| Class | Origin | Chromatographic behaviour |
|---|---|---|
| Deletion sequences | A coupling step that failed silently | Elutes near the target; the classic co-elution risk |
| Truncated sequences | Chains capped early during synthesis | Usually earlier eluting and better resolved |
| Protecting-group adducts | Incomplete final deprotection | Later elution; mass raised by a fixed increment in MS |
| Deamidation products | Asparagine or glutamine hydrolysis during workup or storage | Very close to the target; a one-dalton mass shift |
| Oxidation products | Methionine, tryptophan or cysteine exposed to oxygen or light | Near the target; plus sixteen daltons in MS |
The last two rows carry a point the certificate cannot: purity is not a permanent property. A lot released at 98% was 98% on the analysis date, in the analyzed state. Deamidation and oxidation continue in storage, faster in solution, and the paperwork does not age alongside the vial. A lot held long past its analysis date, or a prepared solution of any age, is running on chemistry the report never measured. The storage and stability guide covers the degradation routes and what slows each of them down.
Verifying the certificate with the laboratory
A certificate is a document, and documents can be reused, edited or invented. Verification is a short procedure, and the fraction of suppliers who pass it cleanly is the most useful market signal there is.
Match the lot first. The identifier on the report, the identifier on the vial label and the identifier on the order paperwork should agree exactly. Then look at who issued the report. An independent laboratory's certificate carries that laboratory's name, address and a report number, and most such laboratories will confirm on request whether a report number is genuinely theirs and which client and lot it was issued for. That single confirmation, one email or one call, collapses most forged paperwork. An in-house certificate is not worthless, since plenty of competent producers test internally, and its chromatogram and mass spectrum can still be judged on their own terms. It simply cannot be independently confirmed, which is the distinction the phrase third-party testing is pointing at.
The recurring red flags are unglamorous: the same chromatogram image appearing across different lots or different compounds, purity figures with no method stated, reports naming no laboratory at all, and analysis dates that precede the lot they describe. Any one of them is a reason to ask questions. Two is a reason to buy elsewhere. What a supplier should provide as a matter of course, per lot and without being asked, is set out in the quality standard.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Common questions
What does 98% peptide purity actually mean?
Does purity tell me how much peptide is in the vial?
Can two laboratories report different purity for the same lot?
What is the difference between purity and identity?
How do I verify a certificate of analysis is genuine?
Sources
- USP General Chapter 621, Chromatography. Compendial conventions for chromatographic procedures, system suitability and peak-area reporting that area-percent purity determinations rest on.
- ICH quality guidelines on specifications (Q6 series). The treatment of identity, purity and assay as distinct test attributes, which is the frame this article applies to peptide certificates.
- Peer-reviewed literature on solid-phase peptide synthesis impurity profiles. Deletion, truncation and side-reaction impurity classes and their chromatographic behaviour; described generically because no single paper is load-bearing for the claims.